Congratulations to Dr. Scuoppo who has been awarded an ASH Restart Award to support his ongoing research in novel therapeutics for diffuse large B-cell lymphoma.
March is Colorectal Cancer Awareness Month. HICCC members Debbie Bakes, MD, and Rachael Safyan, MD, discuss prevention, screening, and what’s ahead in colorectal cancer treatment and research.
Ben Izar, MD, and colleagues have created a new technique that can uncovertricks cancer cells use to evade immunotherapies, which could lead to the development of more effective treatments.
Patient advocates and members of the Patient Advocacy Board at the HICCC work to ensure that the patient perspective is a priority when it comes to treatment, care, and research.
A new method that uses CRISPR to simultaneously make thousands of point mutations in human genes is helping researchers understand how subtle changes to genes contribute to cancer and other diseases.
Dr. Fatemeh Momen-Heravi is the recipient of a prestigious Science of the Patient grant to fund her research into the existing racial disparities in head and neck cancer.
The National Accreditation Program for Breast Centers (NAPBC) has re-awarded three-year accreditation to the breast center NewYork-Presbyterian/Columbia University Irving Medical Center.
Meet Dr. Robyn Gartrell, a physician-scientist focused on bringing cutting-edge cancer immunotherapies that have had success in treating adult cancers to childhood cancers.
A new study demonstrates a novel framework for the assessment of patients’ symptoms and clinical findings which was successful in improving the accuracy of GVHD diagnosis.
